The Russell 2000 closed at a record 3,068.42 on Friday, extending a small-cap rally that has pushed three focused ETFs to year-to-date gains above 29 percent.
Back
Russell 2000 hits record as small-cap ETFs post 29% gains
The Russell 2000 closed at a record 3,068.42 on Friday, up 0.51 percent, broadening a rally that lifted the S&P 500 to fresh highs.
The small-cap gauge has returned 21.83 percent year to date and 15.46 percent over six months, according to index data, as investors rotate beyond the mega-cap technology names that drove early 2026 gains.
Three focused ETFs have outpaced the benchmark. The ALPS Medical Breakthroughs ETF (SBIO), which tracks biotech names with drugs in Phase II or III FDA trials, returned 30.65 percent year to date on a 50-basis-point fee. The VictoryShares Small Cap Free Cash Flow ETF (SFLO), screening 200 small-caps for strong free cash flow, gained 34.7 percent. The iShares U.S. Small Cap Value Factor ETF (SVAL), an equally weighted value screen of 250 names, rose 29.2 percent.
The record close reflects broadening participation, with the Russell 2000 advancing 1.11 percent for the week versus the S&P 500's 0.36 percent gain. Cooling inflation — July CPI rose 0.1 percent month over month to a 3.3 percent annual rate — supports expectations for Federal Reserve rate cuts that typically favor smaller, more rate-sensitive companies.
Three ETFs Outpace the Small-Cap Benchmark
SBIO charges 50 basis points to track the S-Network Medical Breakthroughs Index, a biotech screen that captures companies with one or more drugs in Phase II or III FDA trials. The focus on rising innovators has helped the fund return 30.65 percent year to date.
SFLO charges a 49-basis-point fee to track its own index of 200 small-caps with strong free cash flows and high growth metrics. The index operator screens for firms at 120 percent of the capitalization of the largest name in the Russell 2000. The fund has returned 34.7 percent year to date and marks its three-year ETF milestone in December.
SVAL charges 20 basis points to track the equally weighted Russell 2000 Focused Value Select Index. The fund targets 250 small-caps meeting value standards, screening the Russell 2000 for liquidity, leverage, and volatility while excluding the 20 percent least liquid and most leveraged and volatile stocks. It has returned 29.2 percent year to date.
Rate-Cut Bets Underpin Small-Cap Rotation
The record close reflects a broadening of market leadership beyond the mega-cap technology names that dominated early 2026. The Russell 2000 advanced 1.11 percent for the week, outpacing the S&P 500's 0.36 percent gain and the Nasdaq Composite's 0.14 percent rise.
Cooling inflation supports the rotation. July CPI rose 0.1 percent month over month, bringing the annual rate to 3.3 percent, down from June's 3.5 percent. The 10-year Treasury yield slid from 4.73 percent earlier in the month to about 4.61 percent by mid-August, lowering discount rates that weigh most heavily on smaller, longer-duration companies. The Federal Reserve has held the federal funds rate at 3.50 percent to 3.75 percent for four consecutive meetings, with markets pricing in a higher probability of cuts later in 2026.
For investors, the trio of small-cap ETFs offers distinct ways to capture the segment's momentum — whether through biotech innovation, free-cash-flow quality, or value screening. As the Russell 2000 sets records, these funds provide a route to diversification beyond the concentrated large-cap leaders.
This article is for informational purposes only and does not constitute investment advice.
